Moreover, we speculate that regulatory CD8bright cells are expanded by an increased expression of EBV in MS patients, but we also suggest that this could in part be due to insufficient elimination of these cells by e.g. NK cells (CD8-negative and CD8dim cells). The gene discussed is CD8A; the disease is myeloid sarcoma.